The Covid-19 pandemic affected to great extent business operations. In the second quarter of 2020 many regions across the globe continue to make a huge effort, trying to cope with the slowdown of many sectors and industries.
In the second quarter of 2020 venture, capital-backed companies raised 62,9 billion dollars across 4.502 deals globally, according to KPMG insights. Pharma and biotech companies saw increased investment.
More specifically in the second quarter of 2020 in the US venture, capital-backed companies raised 34,3 billion dollars across 2.197 deals. In Europe, in the second quarter of 2020 venture, capital-backed companies raised 10,1 billion dollars across 1.062 deals. Lastly, in Asia in the second quarter of 2020 venture, capital-backed companies raised 16,9 billion dollars across 1.011 deals. Deal value in China raised to 6,1 billion dollars from 5,6 billion dollars in the first quarter of 2020.
Here are the top 10 businesses in Europe that attracted more financings in the second quarter of 2020, according to KPMG data:
- Deliveroo (575 million dollars): The online food delivery company was founded in 2013 and is based in London. The areas that the company is serving are United Kingdon, Netherlands, France, Belgium, Hong Kong, Ireland, Spain, Italy, Australia, Singapore, Kuwait, Puerto Rico, and the United Arab Emirates. It operates in two hundred locations across the above areas. In 2017 the company announced revenue at about 277,1 million pounds.
- N26 (570 million dollars): It is one of the most popular digital banks. The clients of the bank can manage simple, secure, and fast their bank account on the go, their expenses, and set aside money in real-time. The bank was founded in 2013. Its headquarters are in Berlin. The bank covers its services not only in Europe but also in the United States.
- Lilium (275 million dollars): It is a start-up that was founded in 2015 from four friends who they first met while studying at the Technical University of Munich. It is based near Munich in Germany and is developing a revolutionary, on-demand air taxi service. The company employs more than 500 people.
- Arvelle Therapeutics (207,8 million dollars): It is a totally new biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. The company is headquartered in Switzerland, receiving as a start-up financing of 207,8 million dollars, one of the largest initial financing commitments for a European focused biopharmaceutical company.
- ContentSquare (189,1 million dollars): It is an experience analytics platform with offices in Paris. The platform delivers intelligent recommendations that everyone can use to grow revenue, increase Loyalty, and fuel innovation. ContentSquare works with more than 600 companies globally to empower their teams with behavioral insight. The company has also offices in London, New York, San Francisco, Munich, and Tel Aviv.
- Cazoo (156,1 million dollars): Cazoo offers used cars for online purchases. Also delivers the car to the client’s door. If the client isn’t satisfied with the purchase then the company gets the car back, giving a total refund. You can find Cazoo in London.
- Checkout.com (150 million dollars): This company makes payments seem so easy. It was founded in 2012 and nowadays covers ten international offices, supporting thousands of businesses around the world. The company started it’s operation from London.
- BioCatch (145 million dollars): The company was founded in 2010 in Tel Aviv. The BioCatch platform is deployed by major banks and other global enterprises to help manage their digital identity challenges. BioCatch has been recognized for its industry leadership and cutting-edge approach to behavioral biometrics and digital identity in the CB Insights AI 100.
- Starling Bank (123,1 million dollars): Starling is a digital bank, only for mobile users. It was founded in 2014 and it is based in the United Kingdom. The bank focuses on current and business account products.
- Freeline (120 million dollars): Freeline works on the development of innovative gene therapies to change lives. The company was founded in 2015 with headquarters in the United Kingdom.